GSK has picked a novel protein biotech and a genomics biotech as its first collaborators under a $7 billion biobucks deal ...
TipRanks on MSN
GSK subsidiary initiates litigation against AnaptysBio
GSK (GSK) subsidiary Tesaro confirms it has initiated litigation against AnaptysBio (ANAB) in the Delaware Chancery Court. This action contends ...
Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today announced that ProFound Therapeutics and Quotient Therapeutics have entered into separate ...
Investor's Business Daily on MSN
Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street.
Targeted chemotherapy is here. So-called antibody drug conjugates could flip the toxic paradigm on its ear, helping more ...
Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
13hon MSNOpinion
CDC changes stance on vaccine link to autism claims
The CDC updates its stance on vaccines and autism, acknowledging ongoing debate and new evidence. Read more here.
The Global Anxiety Disorder Treatment Market Growth is Driven by Rising Prevalence of Personality Disorders, Mental Health Awareness and Increasing Adoption of Evidence-Based Therapeutics.Austin, Nov.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback